FDA News Release: FDA Requests Removal of all Ranitidine Products (Zantac) from the Market

The U.S. Food and Drug Administration today announced it is requesting manufacturers withdraw all prescription and over-the-counter (OTC) ranitidine drugs from the market immediately. This is the latest step in an ongoing investigation of a contaminant known as N-Nitrosodimethylamine (NDMA) in ranitidine medications (commonly known by the brand name Zantac).

Please click here to read the rest of the FDA News Release.

Statement by Congresswoman Rosa DeLauro (CT-03) (link)

Media Coverage Below:

The New York Times: Zantac Products Should Not Be Sold or Used, F.D.A. Warns, Citing Cancer Danger

Bloomberg: Zantac Makers Asked by FDA to Withdraw Drug on Cancer Concern
WebMD: FDA Requests Zantac Be Pulled From the Market

NPR: FDA Says Zantac Should Be Pulled From Market, Citing Cancer Risk

Fierce Pharma: Zantac, generics ordered off the market after FDA finds they’re a ticking time bomb

Gizmodo: FDA Demands Zantac Heartburn Drug and Generics Pulled Over Carcinogen Fears

The People’s Pharmacy: Ranitidine – Zantac is Going, Going Gone At Last!

Becker’s Hospital Review: FDA asks all drugmakers to pull ranitidine products from the shelves

Refinery 29: The FDA Issued An Immediate Warning To Stop Taking This Popular Antacid

Harvard Health: Ranitidine (Zantac) recall expanded, many questions remain

NPR WUWF South Florida: FDA Says Zantac Should Be Pulled From Market, Citing Cancer Risk

ABC 7 San Francisco: Zantac, all ranitidine products, to be removed from shelves; FDA cites carcinogen concerns

BD News Bangladesh: Zantac products should not be sold or used, FDA warns, citing cancer danger

Apotheke Adhoc (Germany): USA: Ranitidin muss komplett zurück

FDA News Release: FDA Requests Removal of all Ranitidine Products (Zantac) from the Market

See what is being said about Valisure today

Landmark Paper On The Use Of Evidence-Based Drug Quality Scores Underscores Need For Transparency In Pharmaceutical Supply

Study Of Crowdsourced Metformin Tablets From Individuals Reveals Widespread NDMA Contamination

The Global Pharma Supply Chain and COVID-19 Impact — Valisure Video Seminar

Get your medication from the Pharmacy that checks.

Have questions about Valisure and prefer to speak to us directly?

Company

More Info

Legal

For Doctors

FDA News Release: FDA Requests Removal of all Ranitidine Products (Zantac) from the Market

Share this Article

See what is being said about Valisure today

Landmark Paper On The Use Of Evidence-Based Drug Quality Scores Underscores Need For Transparency In Pharmaceutical Supply

Study Of Crowdsourced Metformin Tablets From Individuals Reveals Widespread NDMA Contamination

The Global Pharma Supply Chain and COVID-19 Impact — Valisure Video Seminar

Get your medication from the Pharmacy that checks.

Have questions about Valisure and prefer to speak to us directly?